198 related articles for article (PubMed ID: 19223463)
1. Small-molecule activation of p53 blocks hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia.
Yang J; Ahmed A; Poon E; Perusinghe N; de Haven Brandon A; Box G; Valenti M; Eccles S; Rouschop K; Wouters B; Ashcroft M
Mol Cell Biol; 2009 Apr; 29(8):2243-53. PubMed ID: 19223463
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1.
Ahmed A; Yang J; Maya-Mendoza A; Jackson DA; Ashcroft M
Cell Death Dis; 2011 May; 2(5):e160. PubMed ID: 21593792
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents.
Lou JJ; Chua YL; Chew EH; Gao J; Bushell M; Hagen T
PLoS One; 2010 May; 5(5):e10522. PubMed ID: 20479887
[TBL] [Abstract][Full Text] [Related]
4. Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma.
de Lange J; Ly LV; Lodder K; Verlaan-de Vries M; Teunisse AF; Jager MJ; Jochemsen AG
Oncogene; 2012 Mar; 31(9):1105-16. PubMed ID: 21765463
[TBL] [Abstract][Full Text] [Related]
5. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
[TBL] [Abstract][Full Text] [Related]
6. Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia.
Suzuki H; Tomida A; Tsuruo T
Oncogene; 2001 Sep; 20(41):5779-88. PubMed ID: 11593383
[TBL] [Abstract][Full Text] [Related]
7. Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
El-Khatib M; Geara F; Haddadin MJ; Gali-Muhtasib H
Radiat Oncol; 2010 Nov; 5():107. PubMed ID: 21078189
[TBL] [Abstract][Full Text] [Related]
8. CSB modulates the competition between HIF-1 and p53 upon hypoxia.
Ye XW; Zhang XP; Liu F
Math Biosci Eng; 2019 Jun; 16(5):5247-5262. PubMed ID: 31499711
[TBL] [Abstract][Full Text] [Related]
9. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.
LaRusch GA; Jackson MW; Dunbar JD; Warren RS; Donner DB; Mayo LD
Cancer Res; 2007 Jan; 67(2):450-4. PubMed ID: 17234751
[TBL] [Abstract][Full Text] [Related]
10. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression.
Bárdos JI; Chau NM; Ashcroft M
Mol Cell Biol; 2004 Apr; 24(7):2905-14. PubMed ID: 15024078
[TBL] [Abstract][Full Text] [Related]
12. Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia.
Miyata S; Ishii T; Kitanaka S
Anticancer Res; 2024 Jan; 44(1):49-59. PubMed ID: 38159998
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature.
Lee HJ; Yoon C; Park DJ; Kim YJ; Schmidt B; Lee YJ; Tap WD; Eisinger-Mathason TS; Choy E; Kirsch DG; Simon MC; Yoon SS
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):621-30. PubMed ID: 25544668
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.
Fu Z; Chen D; Cheng H; Wang F
Med Sci Monit; 2015 Jan; 21():318-25. PubMed ID: 25623525
[TBL] [Abstract][Full Text] [Related]
15. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
Tan C; de Noronha RG; Roecker AJ; Pyrzynska B; Khwaja F; Zhang Z; Zhang H; Teng Q; Nicholson AC; Giannakakou P; Zhou W; Olson JJ; Pereira MM; Nicolaou KC; Van Meir EG
Cancer Res; 2005 Jan; 65(2):605-12. PubMed ID: 15695405
[TBL] [Abstract][Full Text] [Related]
17. RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
Ristau J; van Hoef V; Peuget S; Zhu J; Guan BJ; Liang S; Hatzoglou M; Topisirovic I; Selivanova G; Larsson O
Cell Death Dis; 2019 Nov; 10(11):845. PubMed ID: 31699971
[TBL] [Abstract][Full Text] [Related]
18. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.
Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS
Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi R; Mookerjee B; Bhujwalla ZM; Sutter CH; Artemov D; Zeng Q; Dillehay LE; Madan A; Semenza GL; Bedi A
Genes Dev; 2000 Jan; 14(1):34-44. PubMed ID: 10640274
[TBL] [Abstract][Full Text] [Related]
20. Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation.
Kong P; Yu KN; Yang M; Almahi WA; Nie L; Chen G; Han W
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
